FDA approval of a novel non-opioid analgesic will hopefully address the needs of many patients with acute pain and improve ...
Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting the expression or function of Piezo2, a receptor that senses mechanical ...
Mitochondria play a crucial role in maintaining energy balance and cellular health. Recent studies have shown that chronic stress in neuronal mitochondria can have far-reaching effects, not only ...
Ten years of substantial work by Université de Montréal immunologist Nathalie Labrecque's team at the Montreal Clinical ...
More than 500 of USAID’s canceled contracts and about 100 retained contracts include mentions of health matters like HIV/AIDS ...
Venetia Zachariou, PhD, Edward Avedisian Professor and chair of pharmacology, physiology & biophysics at Boston University Chobanian & Avedisian School of Medicine, has received a Distinguished ...
Research reveals howneurogenic connection can directly trigger inflammatory processes, creating pain patterns that challenge ...
VIP36, a new CB1 agonist, targets a cryptic pocket to provide analgesia for chronic pain while minimizing side effects and ...
In simple terms, the Institute explained that the same nerve cells that make us feel full also trigger our cravings for sweets afterward. In fact, they noted that even the "mere perception" of having ...
They have long been considered a potential target for non-opioid-based pain treatment; however, previous attempts to target this pathway have been met with two challenges. First, repeated exposure ...
They have long been considered a potential target for non-opioid-based pain treatment; however, previous attempts to target this pathway have been met with two challenges. First, repeated exposure to ...
The five-year-old Software Acquisition Pathway (SWP) policy authorized by the fiscal year 2020 National Defense Authorization Act is being reemphasized. A new memo from the Secretary of Defense Pete ...